Regents Of The University Of California Tenaya Therapeutics, Inc. Transaction History

Regents Of The University Of California

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$2.64 - $7.64 $2.49 Million - $7.21 Million	-944,324 Reduced 98.27%	16,633 $97,000
Q1 2023 May 05, 2023	SELL	$1.92 - $3.59 $1.28 Million - $2.39 Million	-665,793 Reduced 40.93%	960,957 $2.74 Million
Q3 2022 Nov 02, 2022	BUY	$2.9 - $5.88 $4.72 Million - $9.57 Million	1,626,750 New	1,626,750 $4.72 Million

56.3M

900

400

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $60.4M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

Get notified when there are updates to the investment portfolio of Regents Of The University Of California, based on Form 13F filings with the SEC.

Stay updated on Regents Of The University Of California with notifications on news.